Skip to main content
. Author manuscript; available in PMC: 2022 Apr 8.
Published in final edited form as: Circulation. 2021 Jun 17;144(3):e41–e55. doi: 10.1161/CIR.0000000000000986
Reviewer Disclosures
Reviewer Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Joseph Carver The University of Pennsylvania None None None None None None None
Joerg Herrmann Mayo Clinic None None None None None Amgen*; Bristol-Myers Squibb*; Takeda Ariad* None
Eric H. Yang UCLA None None None None None None None
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.